Upper LobbyTeam ALL-IN
Alzheimer’s disease is the 6th leading cause of death in the United States, with one in three senior citizens dying of Alzheimer’s or some other form of dementia. Families are left to watch their loved ones deteriorate, helpless as Alzheimer’s disease claims more and more victims. This disease is currently incurable and almost impossible to diagnose, which is why ALL IN wants to help raise awareness for Alzheimer’s and the need for clinical trials to find a cure. During the Eli Lilly and PRA Health Sciences Summer Challenge Program, we built an educational kit to help connect younger audiences to Alzheimer’s disease and clinical trials. By fostering empathy with an Alzheimer’s patient and their family while also learning the science behind the disease, our hope is to motivate people, especially young people, to innovate the clinical trial process getting medicines to those who need them faster.
Most people are familiar with the basics of Alzheimer’s disease, a forgetfulness that becomes debilitating and eventually life ending, but many people do not understand the causes and progression of the disease. Our kit was made to convey the science of Alzheimer’s to people in an approachable way through an emphasis on interactivity. The kit combines a compelling patient story; engaging, educational activities; and follow-up tasks that combine multiple intelligences, targeting learning diversity.
We want to take people on an adventure with our story and the various activities that go with it. By investing our audiences emotionally through a patient centered story, we hope to spread awareness and positivity about clinical trials. Our kit also utilizes many educational methods in order to educate the public about Alzheimer’s disease, and attempts to ease the stress of caring for a person with Alzheimer’s.
Education is changing, in and out of the classroom, and our kit sits at the forefront of this revolution. With our interactive and emotionally engaging content, we hope to educate people on the effects of Alzheimer’s and the importance of clinical trials. We are Team ALL IN, and we are all in to stop Alzheimer’s disease.